Patients with cirrhosis had a higher proportion of HBeAg positivity (26.4% vs. 16.0% vs. 11.2%), a higher proportion of thrombocytopenia (38.3% vs. 21.3% vs. 15.2%), a higher proportion of FIB-4 (> 3.6: 33.3% vs. 22.0% vs. 10.8%), and lower proportion of PLR > 101.1(33.1% vs. 40.7% vs. 52.0%), and smaller tumor diameter (4.0 cm vs. 4.75 cm vs. 5.8 cm) compared to those with minor and advanced fibrosis; however, they had normal ALT levels (36.9% vs. 38.7% vs. 42.4%). This evidence concerns the gene GPT and Thrombocytopenia.